TREATMENT OPTIONS FOR PATIENTS WITH STAGE-D1 (T0-3,N1-2,M0) ADENOCARCINOMA OF PROSTATE

被引：68
|
作者：
ZINCKE, H [1 ]
UTZ, DC [1 ]
THULE, PM [1 ]
TAYLOR, WF [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,MED RES STAT SECT,ROCHESTER,MN 55905
来源：
UROLOGY | 1987年 / 30卷 / 04期
关键词：
D O I：
10.1016/0090-4295(87)90290-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：307 / 315
页数：9
相关论文
共 50 条
  • [21] THE PATIENT, DISEASE STATUS, AND TREATMENT OPTIONS FOR PROSTATE-CANCER - STAGE-D1 AND STAGE-D2
    SCHMIDT, JD
    PROSTATE, 1983, 4 (05): : 493 - 501
  • [22] Early prostate cancer (T1–2N0M0)
    Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1475 NW 12th Ave, Suite 1500, Miami
    FL
    33136, United States
    Intensity-Modulated Radiat. Therapy: Clinical Evid. and Techniques, (355-378):
  • [23] IMPACT OF ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH T1N1M0/T2N0M0 GASTRIC CANCER
    Chen, Yi Fu
    Le, Puo-Hsien
    Chen, Tsung Hsing
    Kuo, Chia Jung
    Wang, Shang Yu
    Chou, Wen Chi
    Yeh, Ta Sen
    Hsu, Jun Te
    GASTROENTEROLOGY, 2024, 166 (05) : S669 - S669
  • [24] Solid component proportion is an important predictor of tumor invasiveness in clinical stage T1N0M0 (cT1N0M0) lung adenocarcinoma
    Li, Meng
    Wu, Ning
    Zhang, Li
    Sun, Wei
    Liu, Ying
    Lv, Lv
    Ren, Jiansong
    Lin, Dongmei
    CANCER IMAGING, 2018, 18
  • [25] Solid component proportion is an important predictor of tumor invasiveness in clinical stage T1N0M0 (cT1N0M0) lung adenocarcinoma
    Meng Li
    Ning Wu
    Li Zhang
    Wei Sun
    Ying Liu
    Lv Lv
    Jiansong Ren
    Dongmei Lin
    Cancer Imaging, 18
  • [26] Pulmonary adenocarcinoma T1N0M0 and its classification
    Weissferdt, Annikka
    Walsh, Garrett
    Kaiser, Larry
    Moran, Cesar A.
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2014, 31 (04) : 260 - 264
  • [27] NONSURGICAL MANAGEMENT OF PATIENTS WITH STAGE-D1 ADENOCARCINOMA OF PROSTATE - RISKS VS BENEFITS
    WHITE, RD
    UROLOGY, 1984, 24 (05) : 12 - 15
  • [28] Breast cancers T1a,b N0 M0 (RPC 2013)
    Lacroix-Triki, M.
    Jacot, W.
    Belkacemi, Y.
    Dalenc, F.
    Cottu, P.
    Rodrigues, M.
    Coeffic, D.
    ONCOLOGIE, 2013, 15 (12) : 637 - 672
  • [29] Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/N0, M0) adenocarcinoma of the prostate
    Zagars, GK
    Pollack, A
    Smith, LG
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (04): : 809 - 819
  • [30] Prognostic value of quantitative cytometry in a series of 415 T1T2/N0N1/M0 breast cancer patients - Preliminary results
    Bolla, M
    Seigneurin, D
    Winckel, P
    MarronCharriere, J
    Panh, MH
    Pasquier, D
    Chedin, M
    Payan, R
    Merlin, F
    Colonna, M
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (10) : 1680 - 1685
12345